By rray, 27 June, 2024 Initiate at least moderate intensity 30 49 LDL C lowering statin tx nbsp nbsp pitavastatin 4 mg qd AI nbsp nbsp atorvastatin 20 mg qd AII nbsp nbsp rosuvastatin 10 mg qd AII
By rray, 27 June, 2024 Data are insufficient to recommend for or against statin tx as 1 ASCVD prevention In the general population lifestyle modifications are recommended for people
By rray, 27 June, 2024 If pregnant Defer statin tx initiation until after pregnancy in pts at low to intermediate ASCVD risk If on statin tx discontinue Breastfeeding is not recommended while on statin tx
By rray, 27 June, 2024 Atorvastatin and rosuvastatin interact w ritonavir and cobicistat boosted ARVs
By rray, 27 June, 2024 Initiate high intensity 50 LDL C lowering statin tx at max tolerated dose nbsp nbsp atorvastatin 40 80 mg qd nbsp nbsp rosuvastatin 20 40 mg qd
By rray, 24 June, 2024 If initial CSF pleocytosis repeat CSF exam q6mo until cell count normal if CSF cell count not darr after 6mo or if cell count protein not normal after 2y consider re tx